Navigation Links
Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update
Date:2/21/2012

met pre-defined specifications and were released for clinical use in the PEARL-SC clinical study. The data from these GMP campaigns were submitted to FDA as a part of the Comparability Plan for blisibimod.

Management

  • Anthera announced the promotion of Dr. Debra Odink to the role of Chief Technology Officer and Senior Vice President.  Dr. Odink has served as Anthera's Senior Vice President of Pharmaceutical Research and Development since 2005.  Dr. Odink assumes the responsibility of overseeing all aspects of clinical pharmacology, non-clinical sciences product and process development activities.

  • *SELENA-SLEDAI -- Safety of Estrogen in Lupus Erythematosus National Assessment / Systemic Lupus Erythematosus Activity Index is a cumulative, weighted index of systemic lupus erythematosus disease activity.

    About Anthera Pharmaceuticals

    Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has three late stage clinical products: varespladib methyl (A-002), A-001 and blisibimod (A-623).  Varespladib methyl (A-002) and A-001 are designed to inhibit a novel enzyme target known as secretory phospholipase A2 (sPLA2). Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease. Blisibimod targets elevated levels of B-lymphocyte stimulator (BAFF) which have been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (lupus) and rheumatoid arthritis.  

    Safe Harbor Statement

    Any statements contained in this press release that refer to future events or other non-historical matters, including statements that are preceded by, f
    '/>"/>

    SOURCE Anthera Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
    2. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
    3. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
    4. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
    5. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
    6. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
    7. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
    8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
    9. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
    10. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
    11. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... Quietly, sedately, Morocco,s pharmaceutical sector is shining. ... is strong, with a well-developed base of local producers ... One place where the quality of Moroccan pharma ... quietly become the second largest African exporter of drugs ... Moroccan pharma companies have been making inroads as exporters ...
    (Date:7/31/2015)... CHICAGO , July 31, 2015 ... Composition Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy ... and Hydrostatic Weighing) - Global Analysis & Forecast to ... Market was pegged at $911.1 Million 2014 and is ... at a CAGR of 9.4% from 2014 to 2019. ...
    (Date:7/30/2015)... IRIDEX Corporation (NASDAQ: IRIX ) today ... financial results after the market closes on Thursday, ... the Company will host a conference call with the ... Thursday, August 6, 2015 to discuss ... Interested parties may access the live conference ...
    Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
    ... ANTONIO, May 10, 2012 /PRNewswire-iReach/ -- ... a unique and innovative chronic wound treatment device, ... (Commerce City, CO) existing Federal Supply Schedule (FSS) ... (VA). The TransCu O2 ® , a noninvasive, ...
    ... LOUIS, May 9, 2012 Young Innovations, Inc. (NASDAQ ... declared a quarterly dividend of $0.04 per share, payable ... May 23, 2012. Young Innovations develops, manufactures ... hygienists, dental assistants and consumers. The Company,s consumables product ...
    Cached Medicine Technology:New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program 2New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program 3Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend 2
    (Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins are ... and women often causing pain and discomfort. Those who spend a lot of time ... Northeast Houston Vein Center is doing what it can to create awareness and provide ...
    (Date:8/1/2015)... ... , ... Tina Wilcoxson, owner of Freeport Maine’s Royal River Natural Foods, was ... National Retail Federation, the largest retail trade association in the world, for her “advocacy ... to be named as such. According to the NRF’s website, Retail Champions are “Main ...
    (Date:8/1/2015)... ... August 01, 2015 , ... Professional Orthopedic and ... has acquired Premier Physical Therapy & Wellness (“Premier”) — with 13 locations in ... , “Our acquisition of Premier Physical Therapy & Wellness solidifies Professional as the ...
    (Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, ... to download on the Apple AppStore. , The app is designed to track ... acting as a tool to view personal health and use this information for positive ...
    (Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... “ reTXT ... look at the latest and coolest applications on the market for iOS, Android, and ... and shared with viewers allows users to clarify, edit and delete any message including ...
    Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Local Retail Advocate Wins National Recognition 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2
    ... scientific, and business arenas convened for the 17th ... Session. Held April 23-25th 2009, this event ... (A4M; www.worldhealth.net ), the academic leader in ... extension that impacts more than 550,000 physicians and ...
    ... Nash Corporation (Nasdaq: KNSY ) is scheduled ... Lynch 2009 Health Care Conference at The Palace Hotel ... W. Kaufmann, Kensey Nash,s President & CEO, will deliver ... To hear the live webcast of the Kensey ...
    ... Importance of Washing their HandsANN ARBOR, Mich., April ... pandemic continue to surface internationally. New cases have ... and eight countries. This includes a twenty-three month ... first reported fatality outside of Mexico.(Logo: ...
    ... 30 The Coalition for Pulmonary Fibrosis (CPF) is pleased ... Marsden on Country Music Television (CMT),s CMT Insider ... p.m. CDT. The interview was taped at the recent ... the family of the late Dennis Linde in Nashville at ...
    ... developing leukemia as a side effect of a drug for ... a study presented as part of the Late-breaking Science Program ... Seattle, April 25 - May 2, 2009.Mitoxantrone is an immunosuppressant ... of advancing MS. It is one of only two drugs ...
    ... Kris Clark, Ph.D., R.D., F.A.C.S.M., Clarifies This Year,s Popular Diet ... Track for Spring/SummerWASHINGTON, April 30 Spring. It,s the ... and renew the weight-loss vows we made back in January ... Each year, millions of Americans follow the latest and ...
    Cached Medicine News:Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 2Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 3Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 4Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 5Health News:Hand Washing Can Help Fight Against the Swine Flu 2Health News:Actor James Marsden To Appear on CMT Insider May 2, Talk About Pulmonary Fibrosis 2Health News:Actor James Marsden To Appear on CMT Insider May 2, Talk About Pulmonary Fibrosis 3Health News:Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought 2Health News:Do Fad Diets Really Work? 2Health News:Do Fad Diets Really Work? 3Health News:Do Fad Diets Really Work? 4
    ... an integrated system that will perform venous ... it. You no longer need to manually ... inflow with and without reactive hyperemia are ... time for measurements and the frequency with ...
    ... of an exciting new range of ... Coherence Reflectometry) technology,our Slitlamp-mounted* Pachymeter offers ... and this non-contact.,This allows pachymetry ... time,and without concerns about sterilization, false ...
    ... The Paradigm Pachymetric Analyzer is designed ... employing unique digital signal processing algorithms. During ... a reading if the probe is +1.5 ... assured of highly accurate results, every time. ...
    ... a minimally invasive cryocatheter to treat ... a very high level of safety ... precision, minimal tissue disruption, and minimal ... is a flexible, single-use, minimally invasive ...
    Medicine Products: